Trump's threat of a 200% tariff on pharmaceutical products can have severe implications on Indian drugmakers, as exports to ...

Lupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The ...

Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...

Global Pharma major Lupin Limited and Zentiva Group, a pan-European pharmaceutical company, have entered into a license and ...

Asian Paints sells stake in Akzo Nobel India, GAIL extends gas agreement, SEBI proposes new guidelines, companies announce ...

It is indicated for various diseases including heumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...

Lupin Ltd has entered into a License and Supply Agreement with Zentiva, k.s., for commercialization of Lupin's biosimilar Certolizumab Pegol.

The move is part of Lupin's broader strategy to create a specialised consumer healthcare entity, particularly aimed at ...

Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...

Pharmaceutical major Lupin Limited has announced the strategic spin-off of its consumer healthcare business, LupinLife ...

Lupin Limited announces the spin-off of its consumer healthcare division, LupinLife Consumer Healthcare Ltd., into a wholly ...

Mumbai: Global pharma major Lupin Limited, has announced the strategic carve-out of its consumer healthcare business, ...